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20 yr have elapsed since the discovery of the association
of the then novel bacterium 
 
Helicobacter pylori
 
 with different
gastroduodenal diseases, including severe active chronic
gastritis, gastroduodenal ulcers, adenocarcinoma, and lym-
phoma (1). The amount of research performed from the
clinical to the molecular level is impressive (2). It is presently
well established that 
 
H. pylori
 
 infects the large majority of
the human population with a very high prevalence in
countries with poor hygienic conditions. 
 
H. pylori
 
 is human
specific and resides in a defined ecological niche comprising
the stomach mucus layer and the stomach epithelial lining.
The infection is chronic and life lasting if not treated with
antibiotics. Only a minority of the infected persons develop
gastroduodenal diseases, suggesting that an adverse out-
come of the infection depends strongly on the response of
the host and/or on the interplay with the genetic back-
ground and other factors. As a result, our present knowledge
of the molecular and cellular steps of the pathogenesis of
the 
 
H. pylori
 
–associated diseases is very limited. An addi-
tional difficulty is that in vitro experiments must be per-
formed within short time windows of hours to weeks,
whereas in vivo the disease develops over years to several
decades. Moreover, the pathogenesis in animal models of
infection differs substantially with the human disease.
 
The VacA Toxin.
 
It is conceivable that a bacterium
causing a life-lasting infection has evolved to produce many
factors that permit colonization and prolonged persistence
in the unique environment of the stomach. Several virulence
factors of 
 
H. pylori
 
 have been identified, and their mechanisms
of action at the cellular and tissue level are being actively
investigated. One factor that has attracted major attention is
the vacuolating cytotoxin (abbreviated VacA), which was
first identified as a protein present in 
 
H. pylori
 
 supernatants
that was capable of inducing the formation of membrane-
bound vacuoles in cells in culture (3, 4). This toxin is made
in the bacterial cytosol as a four-part protein consisting of
(a) an inner membrane secretion signal sequence of variable
nature, which is responsible for the fact that different 
 
H.
pylori
 
 strains secrete different amounts of VacA; (b) a 37-kD
domain (p37) essential for the vacuolating activity; (c) a 58-kD
domain (p58) essential for receptor binding; and (c) an
autotransporter domain, which drives VacA (p37-p58)
across the bacterial outer membrane and is then removed
by specific proteolytic cleavage. VacA may remain associated
with the bacterial surface or be released in the medium. In
water, monomeric VacA has a strong tendency to form
flower-shaped oligomers (5) of low vacuolating activity.
Oligomers are dissociated by acids or bases leading to a
strong increase in activity (6–8).
 
VacA Functions as an Anion Channel.
 
VacA binds to a
variety of cells in culture with a composite binding curve,
suggesting the presence of a limited number of high affinity
binding sites and a large number of low affinity binding
sites. The high affinity sites may be tentatively attributed to
the several cell surface molecules capable of VacA binding
described so far—protein tyrosine phosphatases 
 
 
 
 (8) and 
 
 
 
(9), a GPI-anchored protein associated to rafts (10), and the
EGF receptor (11)—whereas the nonsaturable low affinity
sites are likely to be lipids, since VacA binds to liposomes
and to planar lipid bilayers increasing their ionic permeability
(12–16). Monomeric VacA has a tendency to insert into
membranes where it forms hexameric anion-specific channels
(7, 13, 17). Such channels assemble also in the plasma
membrane of cells increasing permeability to small anions,
including chloride, bicarbonate, and piruvate with conse-
quent membrane depolarization (18). VacA also forms anion-
specific channels in the apical membrane of the epithelial
cells of the stomach mucosa (19) leading to the suggestion
that such VacA activity may benefit the apically residing 
 
H.
pylori
 
 by allowing it to gather anions such as bicarbonate
and piruvate, which are both nutrients and pH buffers (20).
VacA also appears to act at the apical membrane to increase
the paracellular route of transepithelial permeability to ions
essential for 
 
H. pylori
 
, such as iron and nickel, and to small
sugars (21). Though the molecular mechanism of such an
activity has not yet been worked out, its significance in
terms of promotion of bacterial growth is apparent, partic-
ularly if one considers that the mucus layer which covers
and protects the stomach epithelial lining is not permeable
in the lumen-mucosa direction to protons and many small
molecules (20). Therefore, VacA may allow 
 
H. pylori
 
 to reside
in a nutrient-deficient and rather neutral pH environment.
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Immunosuppressive Functions of VacA.
 
After membrane
binding and pore formation, VacA is slowly endocytosed
and it reaches the limiting membrane of late endosomal
compartments (22, 23). Vacuoles originate from late endo-
somes and lysosomes and require the proton-pumping ac-
tivity of the vacuolar-type ATPase pump (v-ATPase) (24,
25). During its journey inside the cell along the endocytic
route, VacA is believed to preserve its anion channel activ-
ity, since this is not affected by the acidic pH of the lumen
of endosomes (14, 15). All the available evidence indicate
that the combined actions of the v-ATPase and of the
VacA anion channel cause an increase of the osmotic pres-
sure inside late endosomal compartments, which swell to
form vacuoles (20). In this way, VacA causes the release of
lysosomal hydrolases into the extracellular medium and in-
hibits the hydrolysis of all molecules which are normally
degraded within late endosomes and lysosomes, such as
ligands, receptors, and antigens (26).
The antigen-processing compartment of antigen-pre-
senting cells is homologous to late endosomes (27), and
VacA was found to profoundly affect the processing of the
model antigen tetanus toxin by human antigen-presenting
cells in such a way that the proliferation of tetanus toxin-
specific T cells was strongly reduced (28). This led to the
proposal that VacA could exert a local immunosuppressive
activity by inhibiting antigen presentation within the stom-
ach mucosa (28). Given that VacA vacuolates almost any
cell type, such inhibition should not be antigen specific.
The VacA immunosuppressive activity has not been tested
in vivo, but it is in line with the finding that 
 
H. pylori
 
 infec-
tion of mice infected with vaccinia virus reduces the vac-
cinia-specific cytotoxic T cell response and prolongs the vi-
ral infection (29).
Two papers (30, 31) now strongly support the possibility
that VacA is immunosuppressive, but the mechanism they
describe involves a direct action on T cells rather than anti-
gen-presenting cells. They show that the toxin inhibits the
proliferation of T cells induced by polyclonal activators.
Purified VacA or different strains of VacA-producing 
 
H.
pylori
 
, but not isogenic VacA mutants, when added to Jur-
kat cells or to peripheral blood lymphocytes inhibited their
proliferation induced by phytohemagglutinin plus phorbol
myristate acetate, or the induction of CD69 expression by
CD3 cross-linking. VacA did not distinguish between
CD4
 
 
 
 and CD8
 
 
 
 T cells since both were inhibited in the
same way (31). T lymphocyte activation and proliferation is
strongly promoted secretion of IL-2 in parallel with expres-
sion on the cell surface of the high affinity IL-2 receptor.
VacA was found to inhibit this autocrine loop as both IL-2
and IL-2 receptor production were reduced. Notably, a
single bacterium per Jurkat cell was sufficient to cause a sig-
nificant reduction of IL-2 secretion (30), implying that
even minute amounts of VacA, similar to those that may be
present in vivo, are sufficient to cause the effect. This im-
plies that high affinity VacA receptors are present in human
lymphocytes, and indeed this was found to be the case (31).
Boncristiano et al. (31) noticed that the 58-kD COOH-
terminal domain of VacA (p58), which lacks the NH
 
2
 
-ter-
minal p37 domain required for channel formation, was also
inhibitory. This questions the involvement of the anion
channel activity of VacA in T cell inhibition. In fact, p58 is
also devoid of cell vacuolating activity (32, 33).
 
Two Pathways of T Cell Inhibition.
 
T cell activation and
production of cytokines, including IL-2, is mediated by an
increase in cytosolic calcium concentration, and it is under
the control of different transcription factors among which
NFAT plays a major role (34). In the resting lymphocyte,
NFAT is cytosolic, and its translocation into the nucleus
follows the dephosphorylation of its nuclear localization
signal by calcineurin, a phosphatase activated by calcium
and inhibited by the immunosuppressive drugs cyclospo-
rine A and FK506 (35). Boncristiano et al. (31) and Gebert
et al. (30) found that VacA inhibits the activation of
NFAT, leaving the other nuclear factors unaffected, and
prevented its migration into the nucleus. This is caused by
the VacA anion channel activity because its effect was
blocked by NPPB (18), a potent inhibitor of the VacA
channel (31). Moreover, when the calcium ionophore
A23187 was used as cell activator the toxin was found to
inhibit the rise of cytosolic calcium. This effect can be ex-
plained, considering that the VacA depolarizes the plasma
membrane (18) and that most of the cytosolic calcium rise
triggered by A23187 follows the opening of a plasma mem-
brane located calcium channel, known as CRAC, which is
closed upon membrane depolarization.
But the finding that p58, which does not form anion
channels and does not affect cytosolic calcium, also inhibits
T cell activation indicates that this is only part of the pic-
ture (31). This is not surprising in the light of the already
mentioned complexity of the cell binding of VacA, which
is thought to involve lipid rafts and cell surface proteins
known to activate tyrosine protein phosphorylation. In-
deed VacA and p58 were found by Boncristiano et al. (31)
to induce phosphorylation of a subset of protein substrates
with a consequent cascade of phosphorylations/activation
events leading to Rac activation and to a reorganization of
the actin cytoskeleton (31), which could inhibit T cell acti-
vation and division. Furthermore, it was shown that Rac
activation, which is known to be coupled to stress kinases
(36–38), correlates with the selective activation of the
stress-activated kinase p38 but not of the related mitogen-
activated kinase Erk (31). The finding that antagonist pep-
tides, which inhibit T cell activation, stimulate the Vav/
Rac/stress kinase pathway, while failing to stimulate other
TCR-mediated signaling pathways, including the Ras/Erk
pathway (39, 40), provides a possible explanation for the
anion channel–independent immunosuppressive activity of
VacA and p58.
 
New Proinflammatory Activities of VacA.
 
Boncristiano et
al. (31) went further by showing that VacA induces phos-
phorylation of p38 in neutrophils and macrophages also.
This nuclear transcription-activating factor controls, among
others, the gene encoding for the proinflammatory enzyme
cyclooxygenase (COX)-2, whose expression was found to 
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be increased upon exposure to VacA. RPTP-
 
 
 
 is a VacA
receptor (8), and it is perhaps relevant in this context that
intragastric administration of VacA to RPTP-
 
 
 
 knockout
mice caused vacuolization with no inflammation, implying
that VacA binding to this protein receptor is necessary for
its proinflammatory activities but not for vacuolization
(41). This is in agreement with the model for VacA-
induced vacuolization, described above, which only re-
quires a VacA anion channel activity localized on late en-
dosomal compartments (20).
 
Toward a Model of VacA Function.
 
Though some aspects
of VacA function require further evidence and experimen-
tation, the ensemble of the current data can be summarized
as in Fig. 1. VacA binds to different protein receptors de-
pending on its concentration and on the cell type. At
higher concentrations, it binds to lipids directly. In addi-
tion, by local detachment from the protein receptor, VacA
may insert into the lipid bilayer, a step expected to be irre-
versible owing to its tendency to form hexameric anion-
selective channels. The different modes of binding are likely
to trigger different cellular responses. The toxin channel
activity causes membrane depolarization, which interferes
with calcium signaling events within the cell. Thus, the rise
of cytosolic calcium mediated by the plasma membrane
channel, which is operated by calcium released from intra-
cellular calcium stores, is strongly inhibited. This prevents
the activation of calcineurin and the consequent dephos-
phorylation of NFAT, which plays a major role in the acti-
vation of the expression of high affinity IL-2 receptor and
cytokines, including IL-2. This causes a pronounced inhi-
bition of the activation and proliferation of T cells. In addi-
tion, via protein receptors which bind VacA and its
COOH-terminal domain p58 with high affinity, protein
tyrosine phosphorylation is somehow promoted, leading to
a Vav-mediated activation of Rac which induces a cyto-
skeletal reorganization that interferes with T cell prolifera-
tion. At the same time, stress kinases are activated with
phosphorylation of p38, in the absence of Erk activation,
which has an anergic effect on T cells. This second path-
way of T cell inhibition occurs at lower toxin concentra-
tion and may, therefore, be of great relevance in vivo (31).
A further analysis will provide a more solid ground to this
mode of T cell inhibition by VacA.
What is already clear from the present work is that VacA
promotes the expression of the proinflammatory enzyme
COX-2, not only in T cells but also in neutrophils and
macrophages. That VacA may have proinflammatory activ-
ity is also suggested by the finding that it activates mast cells
to produce proinflammatory cytokines such as TNF and
IL-6 (42). Proinflammatory activities and immunosuppres-
sive effects are only apparently contradictory. In fact, they
can be rationalized considering that 
 
H. pylori
 
 has evolved to
reside in a nutrient poor ecological niche and to give a
chronic infection. The localized and moderate inflamma-
tion of the stomach mucosa caused by the presence of 
 
H.
pylori
 
 promotes the release from the tissue of nutrients
needed for its growth and this necessity, apparently, cannot
be dealt with in other ways, given the very limited perme-
ability of the stomach mucus layer and of the epithelial lin-
ing. On the other hand, a persistent mucosal infection may
Figure 1. VacA inhibits T cell
activation and proliferation via
two mechanisms. The first is
linked to the anion-selective
channel activity of this toxin
which depolarizes the plasma
membrane and prevents the
opening of the CRAC calcium
channel, which is operated by
the calcium released from intra-
cellular stores. At low cytosolic
calcium, the phosphatase cal-
cineurin does not dephosphory-
late NFAT, thus preventing its
translocation into the nucleus
and the activation of the expres-
sion of IL-2 and IL-2 receptor
necessary for proliferation. In
addition, low doses of VacA or
its COOH-terminal domain p58
(top right side) inhibit T cell acti-
vation by inducing a cascade
of phosphorylation events involv-
ing a still unidentified protein
(brown), Vav, and MKK3/6,
resulting in an increase of the
active form of p38, but not of
Erk, which may induce anergy.
In addition Vav induces actin re-
arrangement through the small
GTPase Rac, which leads to
inhibition of T cell proliferation. 
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benefit from an inhibition of the local immune response.
Although different 
 
H. pylori
 
 molecules have proinflamma-
tory activities, the same virulence factor, VacA, appears to
be both proinflammatory and immunosuppressive depend-
ing on the type of cells it binds to.
In conclusion, all the findings and considerations dis-
cussed in this commentary make sense in terms of cell and
tissue biology, but it remains to be established how and to
what an extent they apply to the in vivo situation. We may
have reached the point where we need to investigate in de-
tail and in quantitative terms the tissue localization of VacA
and the relative amounts found above, inside and below
epithelial cells. We may also have to develop methods to
deliver VacA, or any other 
 
H. pylori
 
 virulence factor, at
precise cellular sites within the stomach mucosa and to de-
termine its effects.
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